Abstract
A new class of dendrimers with open-resorcinarenes has been synthesized in good yields (77-85%). The open-resorcinarenes showed a high capacity for functionalization, having eight hydroxyl groups. The Williamson reaction with N,N-bis(2-azidoethyl)-2-bromo acetamide did not show any steric effect, obtaining sixteen azide terminal groups, which gave us the possibility to obtain a high molecular weight dendrimer via the azide-alkyne click reaction with prop-2-yn-1-yl-(ibuprofen)L-serinate derivatives to obtain the triazole ring spacers and the L-serinate(ibuprofen) derivatives as terminal groups. Also, we carried out the deprotection reaction of the L-serinate moiety terminal groups of the dendrimer 10 in good yields (95%). Three novel open-resorcinarene den-drimers with sixteen ibuprofen-L-serinate derivatives and hydroxyl, tert-butyl, and carboxylic acid; therefore, with three different terminal groups, with possible nanomedical activity are reported.
Keywords: Open-resorcinarenes, dendrimers, L-serine, ibuprofen, click reaction, triazole.
Graphical Abstract
[http://dx.doi.org/10.1295/polymj.17.117]
[http://dx.doi.org/10.1016/j.progpolymsci.2005.01.007]
[http://dx.doi.org/10.1021/ja010524e] [PMID: 11414823]
[http://dx.doi.org/10.1016/j.drudis.2010.01.009] [PMID: 20116448]
[http://dx.doi.org/10.1039/B821019P] [PMID: 20111776]
[http://dx.doi.org/10.3762/bjoc.8.107] [PMID: 23015845]
[http://dx.doi.org/10.2174/1573406415666190826162339] [PMID: 31448714]
[http://dx.doi.org/10.1021/cr900186c] [PMID: 19769361]
[http://dx.doi.org/10.3390/nano7070163] [PMID: 28665319]
[http://dx.doi.org/10.3184/0308234041209176]
[http://dx.doi.org/10.1016/j.bmcl.2020.127275] [PMID: 32527536]
[http://dx.doi.org/10.3390/molecules20059263] [PMID: 26007183]
[http://dx.doi.org/10.1002/wnan.1409] [PMID: 27126551]
[http://dx.doi.org/10.2174/1385272820666151123235059]
[http://dx.doi.org/10.3390/polym8060214] [PMID: 30979310]
[http://dx.doi.org/10.1016/S1359-6446(01)01757-3] [PMID: 11301287]
[http://dx.doi.org/10.1158/1078-0432.CCR-04-1696] [PMID: 15746067]
[http://dx.doi.org/10.3109/03639045.2014.891127] [PMID: 24564798]
[http://dx.doi.org/10.1021/acsabm.0c00179]
[http://dx.doi.org/10.1038/s41598-018-27400-6] [PMID: 29925967]
[http://dx.doi.org/10.3390/pharmaceutics10030162] [PMID: 30235881]
[http://dx.doi.org/10.1016/j.ijpharm.2009.10.017] [PMID: 19825406]
[http://dx.doi.org/10.1002/anie.200603013] [PMID: 17094148]
[http://dx.doi.org/10.1039/C6OB02164F] [PMID: 27735006]
[http://dx.doi.org/10.1039/B9NJ00234K]